← Stock Trading Canary · All insider profiles
INSIDER PROFILE · BE
EcoR1 Capital Fund Qualified, L.P.
Person closely associated to a member of administrative management or supervisory body
Profile key: be|ecor1 capital fund qualified, l.p.
Purchase history
- Companies traded
- 1
- Purchases · 12M
- 0
- Purchases · 24M
- 14
- Average purchase
- USD 2,991,802
- Gross purchase value
- USD 41,885,223
- Last purchase
- 2025-07-28
- Completed 20D events
- 14.0
- Outcome status
- PASS
Latest company: LAKEFRONT BIOTHERAPEUTICS
Companies: LAKEFRONT BIOTHERAPEUTICS
Post-purchase outcomes
Benchmark-relative outcomes are available against BEL 20.
- Excess return = stock return − BEL 20 return over the same period.
- Hit rate = positive excess-return events ÷ completed events.
- Price coverage = valid point-in-time prices ÷ events mature enough for that period.
- Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 14Developing | 100.0% (14/14) | 42.9% (6/14) | -1.1% | -0.7% | -4.0% |
| 20D | 14Developing | 100.0% (14/14) | 35.7% (5/14) | -4.3% | -0.3% | -7.4% |
| 60D | 14Developing | 100.0% (14/14) | 71.4% (10/14) | +1.5% | +0.9% | -13.8% |
| 120D | 14Developing | 100.0% (14/14) | 35.7% (5/14) | -5.3% | -5.2% | -19.9% |
Research patterns
- First purchase in 12M
- 0/9
- Large purchase ≥ €100k
- 14/14
- Cluster buying · 15D
- 14/14
- Buying the dip · ≥20% below prior 52W high
- 0/14
- Routine / opportunistic
- Not classifiable
Counts are profile-wide, point-in-time research labels. They never affect the insider score or ranking.
Every completed outcome is shown; n<5 is descriptive small-sample evidence and is not scored. Disclosure-level observations published on the same date may share a return path and may not be statistically independent. These results never affect the insider score or ranking.